Determinants of VIA Positivity Among Women Screened for Cervical Precancerous Lesion in Public Hospitals of Oromia Region, Ethiopia: Unmatched Case-Control Study

References

• ACF (Anti cancer Fund). Cervical Cancer: A Guide for Patients - Information Based on ESMO Clinical Practice Guidelines. Vol. 2012; 2012:1.
   Google Scholar
• World Health Organization. IARC Handbooks of Cancer Prevention. Volume 10: Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. Vol. 10. Cervix cancer screening; 2005.
   Google Scholar
• Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186–192. doi:10.1097/00004347-199304000-00018
   PubMed Web of Science ®Google Scholar
• De Vuyst H, Mugo NR, Chung MH, et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer. 2012;107(9):1624. doi:10.1038/bjc.2012.441
   PubMed Web of Science ®Google Scholar
• Bruni L, Barrionuevo-Rosas L, Albero G, et al. 2017. ICO/IARC information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in the world. Summary Report.
   Google Scholar
• WHO(world health organization). Fact sheet on cervical cancer. 2018. Available from: https://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en. Accessed May 11, 2019.
   Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. globocan. iarc. fr; 2012.
   Google Scholar
• Chumworathayi B, Blumenthal PD, Limpaphayom KK, Kamsa-ard S, Wongsena M, Supaatakorn P. Effect of single-visit VIA and cryotherapy cervical cancer prevention program in Roi Et, Thailand: a preliminary report. J Obstet Gynaecol Res. 2010;36(1):79–85. doi:10.1111/j.1447-0756.2009.01089.x
   Web of Science ®Google Scholar
• Horo A, Jaquet A, Ekouevi DK, et al. Cervical cancer screening by visual inspection in Côte d’ivoire, operational and clinical aspects according to HIV status. BMC Public Health. 2012;12(1):237. doi:10.1186/1471-2458-12-237
   Web of Science ®Google Scholar
• Nwankwo KC, Aniebue UU, Aguwa EN, Anarado AN, Agunwah E. Knowledge attitudes and practices of cervical cancer screening among urban and rural Nigerian women: a call for education and mass screening. Eur J Cancer Care (Engl). 2011;20(3):362–367. doi:10.1111/j.1365-2354.2009.01175.x
   PubMed Web of Science ®Google Scholar
• FMOH (Federal Ministry of Health). National Cancer Control of Ethiopia 2016–2020, Disease Prevention and Control Directorate. Addis Ababa, Ethiopia; 2015.
   Google Scholar
• Mitiku I, Tefera F. Knowledge about cervical cancer and associated factors among 15–49 year old women in Dessie Town, Northeast Ethiopia. PLoS One. 2016;11(9):e0163136.
   Web of Science ®Google Scholar
• Bayu H, Berhe Y, Mulat A, Alemu A, Grce M. Cervical cancer screening service uptake and associated factors among age eligible women in Mekelle Zone, Northern Ethiopia, 2015: a community based study using health belief model. PLoS One. 2016;11(3):e0149908. doi:10.1371/journal.pone.0149908
   PubMed Web of Science ®Google Scholar
• WHO(world health organization). Fact sheet on cervical cancer. 2013. Available from: http://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/. Accessed April 5, 2018.
   Google Scholar
• American College of Obstetricians and Gynecologists. Committee on adolescent health care, immunization expert work group. Committee Opin Number. 2015;126:e38–e43. human papillomavirus vaccination.
   Google Scholar
• Campos NG, Castle PE, Wright TC, Kim JJ. Cervical cancer screening in low‐resource settings: a cost‐effectiveness framework for valuing tradeoffs between test performance and program coverage. Int J Cancer. 2015;137(9):2208–2219. doi:10.1002/ijc.29594
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Barrionuevo-Rosas L, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Global Health. 2016;4(7):e453–e463. doi:10.1016/S2214-109X(16)30099-7
   PubMed Web of Science ®Google Scholar
• Denny L, Quinn M, Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine. 2006;24:S71–S77. doi:10.1016/j.vaccine.2006.05.121
   Web of Science ®Google Scholar
• World Health Organization. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention: Supplemental Material: GRADE Evidence-To-Recommendation Tables and Evidence Profiles for Each Recommendation; 2013.
   Google Scholar
• Gaffikin L, Blumenthal PD, McGrath J, Chirenje ZM. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary care setting. Lancet. 1999;353(9156):869.
   Web of Science ®Google Scholar
• Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynecol Obstet. 2005;89:S2. doi:10.1016/j.ijgo.2005.01.009
   Web of Science ®Google Scholar
• Sankaranarayanan R, Wesley R, Thara S, et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol’s iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer. 2003;106:404–408. doi:10.1002/ijc.11245
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R, Basu P, Wesley RS, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer. 2004;110(6):907–913. doi:10.1002/ijc.20190
   PubMed Web of Science ®Google Scholar
• Belinson JL, Pretorius RG, Zhang WH, et al. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol. 2001;98:441–444.
   PubMed Web of Science ®Google Scholar
• Bezabih M, Tessema F, Sengi H, Deribew A. Risk factors associated with invasive cervical carcinoma among women attending Jimma University specialized hospital, Southwest Ethiopia: a case control study. Ethiop J Health Sci. 2015;25:345–352. doi:10.4314/ejhs.v25i4.8
   Google Scholar
• Teame H, Addissie A, Ayele W, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case control study. PLoS One. 2018;13(1):e0191506. doi:10.1371/journal.pone.0191506
   Web of Science ®Google Scholar
• Getinet M, Gelaw B, Sisay A, Mahmoud EA, Assefa A. Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC Clin Pathol. 2015;15(1):16. doi:10.1186/s12907-015-0016-2
   PubMedGoogle Scholar
• Kassa RT. Risk factors associated with precancerous cervical lesion among women screened at Marie Stops Ethiopia, Adama town, Ethiopia 2017: a case control study. BMC Res Notes. 2018;11(1):145. doi:10.1186/s13104-018-3244-6
   Google Scholar
• Hailemariam T, Yohannes B, Aschenaki H, et al. Prevalence of cervical cancer and associated risk factors among women attending cervical cancer screening and diagnosis center at Yirgalem General Hospital, Southern Ethiopia. J Cancer SciTher. 2017;9:730–735. doi:10.4172/1948-5956.1000500
   Google Scholar
• Gessese Z, Tadesse Z, Alemayehu M, et al. Determinant factors of Visual Inspection with Acetic Acid (VIA) positive lesions among HIV positive women in Mekelle Hospital, Northern Ethiopia: a case control study. Ethiop Med J. 2015;53.
   Google Scholar
• Castellsague X, Munoz N. Chapter 3: cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;2003(31):20–28. doi:10.1093/oxfordjournals.jncimonographs.a003477
   Google Scholar
• Jensen KE, Schmiedel S, Norrild B, et al. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer. 2013;108(1):234–239. doi:10.1038/bjc.2012.513
   Web of Science ®Google Scholar
• Makuza JD, Nsanzimana S, Muhimpundu MA, Pace LE, Ntaganira J, Riedel DJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22(1). doi:10.11604/pamj.2015.22.26.7116
   PubMedGoogle Scholar
• Cohen O, Schejter E, Agizim R, et al. Postcoital bleeding is a predictor for cervical dysplasia. PLoS One. 2019;14(5):e0217396. doi:10.1371/journal.pone.0217396
   PubMed Web of Science ®Google Scholar
• Roura E, Castellsague X, Pawlita M, et al. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer. 2014;135(2):453–466. doi:10.1002/ijc.28666
   PubMed Web of Science ®Google Scholar
• Fang J-H, Yu X-M, Zhang S-H, Yang Y. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies. J Cancer Res Ther. 2018;14(8):184–189. doi:10.4103/0973-1482.179190
   PubMed Web of Science ®Google Scholar
• Gedefaw A, Astatkie A, Tessema GA, Atashili J. The prevalence of precancerous cervical cancer lesion among HIV-infected women in Southern Ethiopia: a cross-sectional study. PLoS One. 2013;8(12):e84519. doi:10.1371/journal.pone.0084519
   Web of Science ®Google Scholar
• Izudi J, Adrawa N, Amongin D. Precancerous cervix in human immunodeficiency virus infected women thirty years old and above in Northern Uganda. Hindawi Publishing Corporation. J Oncol. 2016;7. doi:10.1155/2016/5473681
   Web of Science ®Google Scholar
• Utoo BT, Utoo PM, Ngwan SD, Anzaku SA, Daniel MA. Cervical intraepithelial neoplasia: prevalence, risk factors, and utilization of screening services among an urban population in Nigeria. Trop J Obstet Gynaecol. 2016;33(3):279. doi:10.4103/0189-5117.199810
   Google Scholar